PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 12, 2021
4 Jan 12, 2021
424B4 Jan 7, 2021 424B4
EFFECT Jan 6, 2021
S-1MEF Jan 6, 2021 S-1MEF
CORRESP Jan 4, 2021
CORRESP Jan 4, 2021
8-K Jan 4, 2021 8-K
S-1 Jan 4, 2021 S-1
UPLOAD Dec 23, 2020
DRS Dec 21, 2020
10-Q Nov 10, 2020 10-Q
8-K Nov 10, 2020 8-K
8-K Nov 4, 2020 8-K
SC 13D Oct 5, 2020 SCHEDULE 13D
4/A Sep 30, 2020 FORM 4/A SUBMISSION
4 Sep 30, 2020 FORM 4 SUBMISSION
4 Sep 30, 2020 FORM 4 SUBMISSION
4 Sep 30, 2020 PRIMARY DOCUMENT
SC 13D Sep 30, 2020 SC 13D
4 Sep 29, 2020 FORM 4 SUBMISSION
4 Sep 29, 2020 FORM 4 SUBMISSION
4 Sep 29, 2020 FORM 4 SUBMISSION
4 Sep 29, 2020 FORM 4 SUBMISSION
4 Sep 29, 2020 FORM 4 SUBMISSION
← Newer Page 14 of 16 · 389 filings Older →